SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001999371-24-002333
Filing Date
2024-02-14
Accepted
2024-02-14 16:35:18
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ownership.html 5  
1 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ownership.xml 5 6083
  Complete submission text file 0001999371-24-002333.txt   7771
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6 SHENNONG ROAD, TORCH DEVELOPMENT ZONE ZHONGSHAN, GUANGDONG F4 528437
Business Address
Xia Yu (Reporting) CIK: 0001963544 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36866 | Film No.: 24639308